Literature DB >> 28040597

Marine actinobacteria as a drug treasure house.

Syed Shams Ul Hassan1, Abdul Lateef Shaikh2.   

Abstract

Marine actinobacteria have been considered as a gold mine with respect to great potential regarding their secondary metabolites. Most of the researches have been conducted on actinobacteria's derived secondary metabolites to examine its pharmacological properties. Actinobacteria have a potential to provide future drugs against crucial diseases, such as drug-resistance bacteria, cancer, a range of viral illnesses, malaria, several infections and inflammations. Although, the mode of action of many bio molecules are still untapped, for a tangible number of compounds by which they interfere with human pathogenesis are reported here with detailed diagrammed illustrations. This knowledge is one of the basic vehicles to be known especially for transforming bio medicinal molecules to medicines. Actinobacteria produce a different kind of biochemical substances with numerous carbon skeletons, which have been found to be the main component interfering with human pathogenesis at different sites. Different diseases have the capability to fight at different sites inside the body can lead to a new wave of increasing the chances to produce targeted medicines.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory activity; Anticancer activity; Bio medicinal molecules; Chemical structures; Marine actinobacteria; Medicines

Mesh:

Substances:

Year:  2016        PMID: 28040597     DOI: 10.1016/j.biopha.2016.12.086

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

Review 1.  Marine Microbial-Derived Resource Exploration: Uncovering the Hidden Potential of Marine Carotenoids.

Authors:  Ray Steven; Zalfa Humaira; Yosua Natanael; Fenny M Dwivany; Joko P Trinugroho; Ari Dwijayanti; Tati Kristianti; Trina Ekawati Tallei; Talha Bin Emran; Heewon Jeon; Fahad A Alhumaydhi; Ocky Karna Radjasa; Bonglee Kim
Journal:  Mar Drugs       Date:  2022-05-26       Impact factor: 6.085

2.  Fluostatins M-Q Featuring a 6-5-6-6 Ring Skeleton and High Oxidized A-Rings from Marine Streptomyces sp. PKU-MA00045.

Authors:  Jing Jin; Xiaoyan Yang; Tan Liu; Hua Xiao; Guiyang Wang; Mengjie Zhou; Fawang Liu; Yingtao Zhang; Dong Liu; Minghua Chen; Wei Cheng; Donghui Yang; Ming Ma
Journal:  Mar Drugs       Date:  2018-03-09       Impact factor: 5.118

3.  Diversity, Novelty, and Antimicrobial Activity of Endophytic Actinobacteria From Mangrove Plants in Beilun Estuary National Nature Reserve of Guangxi, China.

Authors:  Zhong-Ke Jiang; Li Tuo; Da-Lin Huang; Ilya A Osterman; Anton P Tyurin; Shao-Wei Liu; Dmitry A Lukyanov; Petr V Sergiev; Olga A Dontsova; Vladimir A Korshun; Fei-Na Li; Cheng-Hang Sun
Journal:  Front Microbiol       Date:  2018-05-04       Impact factor: 5.640

4.  Insights into Red Sea Brine Pool Specialized Metabolism Gene Clusters Encoding Potential Metabolites for Biotechnological Applications and Extremophile Survival.

Authors:  Laila Ziko; Mustafa Adel; Mohamed N Malash; Rania Siam
Journal:  Mar Drugs       Date:  2019-05-08       Impact factor: 5.118

Review 5.  Chemically Diverse and Biologically Active Secondary Metabolites from Marine Phylum chlorophyta.

Authors:  Sayed Asmat Ali Shah; Syed Shams Ul Hassan; Simona Bungau; Yongsheng Si; Haiwei Xu; Md Habibur Rahman; Tapan Behl; Daniela Gitea; Flavia-Maria Pavel; Raluca Anca Corb Aron; Bianca Pasca; Sebastian Nemeth
Journal:  Mar Drugs       Date:  2020-09-26       Impact factor: 5.118

6.  Diversity and Distribution of Uncultured and Cultured Gaiellales and Rubrobacterales in South China Sea Sediments.

Authors:  Rou-Wen Chen; Yuan-Qiu He; Lin-Qing Cui; Cun Li; Song-Biao Shi; Li-Juan Long; Xin-Peng Tian
Journal:  Front Microbiol       Date:  2021-06-16       Impact factor: 5.640

7.  Activation and enhancement of caerulomycin A biosynthesis in marine-derived Actinoalloteichus sp. AHMU CJ021 by combinatorial genome mining strategies.

Authors:  Yunchang Xie; Jiawen Chen; Bo Wang; Tai Chen; Junyu Chen; Yuan Zhang; Xiaoying Liu; Qi Chen
Journal:  Microb Cell Fact       Date:  2020-08-06       Impact factor: 5.328

8.  Heterologous Expression of a VioA Variant Activates Cryptic Compounds in a Marine-Derived Brevibacterium Strain.

Authors:  Xiao Han; Lukuan Hou; Jing Hou; Yongyu Zhang; Huayue Li; Wenli Li
Journal:  Mar Drugs       Date:  2018-06-02       Impact factor: 5.118

9.  Brocaeloid D, a novel compound isolated from a wheat pathogenic fungus, Microdochium majus 99049.

Authors:  Jingyu Zhang; Zhenzhen Wang; Zhijun Song; Loganathan Karthik; Chengjian Hou; Guoliang Zhu; Lan Jiang; Jianying Han; Rong Ma; Li Li; Lixin Zhang; Xueting Liu; Tom Hsiang
Journal:  Synth Syst Biotechnol       Date:  2019-10-03

10.  New Napyradiomycin Analogues from Streptomyces sp. Strain CA-271078.

Authors:  Daniel Carretero-Molina; Francisco Javier Ortiz-López; Jesús Martín; Daniel Oves-Costales; Caridad Díaz; Mercedes de la Cruz; Bastien Cautain; Francisca Vicente; Olga Genilloud; Fernando Reyes
Journal:  Mar Drugs       Date:  2019-12-26       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.